ACADIA Pharmaceuticals, Inc. Reports Second Quarter 2014 Financial Results
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced its unaudited financial results for the second quarter ended June 30, 2014.
Help employers find you! Check out all the jobs and post your resume.